Experience the life-changing benefits of having LASIK, PRK, or NO-CUT LASIK surgery with Dr. Sandra Belmont, one of the first investigators in the U.S. to participate in FDA trials examining the use of excimer lasers in LASIK.
Belmont Eye Center is proud to offer NO-CUT LASIK and PRK surgery, the safest vision correction treatment options available for prospective patients.
PARK AVENUE’S MOST TRUSTED EYE DOCTOR
Sandra Belmont, MD, a highly regarded, board certified ophthalmologist and LASIK surgeon, has helped tens of thousands of New York patients achieve clear vision without glasses. An undisputed leader in her field, as evidenced by the name recognition of many of her patients, Dr. Belmont has performed over 50,000 eye procedures to date and counting. She is deeply committed to providing the best possible vision correction results for each and every one of her eye surgery patients.
Dr. Belmont has worked with some of the most recognized celebrities as their go to eye doctor. Her combination of sensitivity and attentive listening with a personalized level of care results in optimal long-term results from complex surgical procedures. Belmont Eye Center is the premier location for a personalized level of care in the safety of a top eye surgeon.
A renowned ophthalmologist who is sought after by patients from all parts of the globe, Dr. Belmont prides herself on her attention to details and genuine investment in each patients care. Dr. Belmont is also a coveted lecturer and recipient of numerous awards, including the American Academy of Ophthalmology’s Award for Distinguished Services and the Richard C. Troutman, M.D., Master Teacher Award in Ophthalmology for “her contributions in making laser vision correction the safe and popular procedure that it has become.” Through her highly competitive, one-year corneal fellowship program, Dr. Belmont has trained and mentored 17 cornea-specialist Fellows to date.
PRK, LASIK and their laser vision correction variants are all FDA approved for the treatment of nearsightedness, farsightedness, astigmatism and presbyopia for patients that wish to be unburdened of a dependence on glasses and contact lenses. A comprehensive, thorough examination is effected during your initial consultation to insure that you are a good candidate for the procedure. The exam rules out anything that may disqualify you from benefiting from the treatment. Some conditions that may disqualify a patient include but are not limited to: a visually significant cataract, unusually thin, or unusually shaped corneas, retinal conditions that hinder one’s visual acuity and are not correctable with glasses or contacts, etc… Once all of these have been ruled out, the diagnosis can be limited to either nearsightedness, farsightedness, astigmatism or presbyopia. These manifest as a consequence of the shape of the eye, where the eye is too long or too short (nearsightedness and farsightedness, respectively), or where the cornea is shaped more like a football than a baseball (as is the case for astigmatism). Presbyopia, the age-related inability to focus on near that develops as we reach our fifties can also be addressed with laser vision correction. Dr. Belmont will discuss the LASIK or PRK procedure that is best suited for each patient and explain in detail what to expect during and immediately following the treatment as the patients heal post-operatively. There is no sensation in the course of undergoing a LASIK or PRK procedure and typically, most patients are able to return to work and driving in a matter of days.
To find out more about Dr. Sandra Belmont or eye procedures such as LASIK and No Cut LASIK, please contact us today.
212-486-2020
BEC Beauty is the new non-surgical medical clinic Dr. Belmont has started in the New York City office. We offer advanced beauty enhancement procedures with the latest technology, including Morpheus8 and FaceTite. Contact us for a free virtual consultation below.
Reviewed by Angela Christine Yim, BA; and Yannis Mantas Paulus, MD, FACS A handheld, standalone device provides easy, fast, and comfortable remote monitoring for patients with dry age-related macular degeneration (AMD), according to Angela Yim, BA; and Yannis Mantas Paulus, MD, FACS. Yim is a student at the University of Michigan Medical School in Ann Arbor. […]
Reviewed by Jed Lusthaus, MBBS, MPH, FRANZCO Contrary to what one might expect, the highest IOP spikes can occur 1 week after implantation of the iStent device (Glaukos) viatrabecular bypass surgery, not on postoperative day 1. In addition, investigators have found that hemoglobin video imaging (HVI) may enhance our understanding of IOP control and aqueous […]
Reviewed by Michel Michaelides, MDA gene therapy for a common and severe form of retinitis pigmentosa (RP), RPGR-associated X-linked RP, botaretigene sparoparvovec (MeiraGTx Holdings plc and Janssen Pharmaceuticals), demonstrated improvements in retinal sensitivity and visual function compared with controls and had a manageable adverse event profile, according to Michel Michaelides, MD, from the UCL Institute […]
Reviewed by David S. Boyer, MD When treating diabetic retinopathy (DR), the current approach for physicians remains medical management, specifically maintaining control of blood sugar, blood pressure, and lipids and encouraging smoking cessation. Remarkably, for each 1% decrease in hemoglobin A1C, the risk of complications decreases by 28% to 35%, David S. Boyer, MD, an […]
Reviewed by José-Alain Sahel, MD An optogenetic treatment, GS030-MD (GenSight Biologics), which combines gene therapy and a medical device, demonstrated a good safety profile in the phase 1/2 PIONEER trial (NCT03326336) n patients with end-stage retinitis pigmentosa (RP), according to José-Alain Sahel, MD. RP, a genetic disease that results from mutations in more than 100 […]
I am proud to be an ophthalmologist. We are fortunate to be in a field that is at the forefront of technological advancement, research development, and surgical innovation in medicine. However, though we lead in many aspects, ophthalmology has notoriously lagged behind other medical specialties with regards to diversity, equity, and inclusion. The statistics on […]
